Company Overview and News

 
G-20 finance meeting kicks off as leaders focus on free trade amid U.S. protectionism

15h japantimes.co.jp
WASHINGTON – Group of 20 finance leaders began a two-day meeting in Washington on Thursday, with trade issues high on the agenda as the United States pushes ahead with protectionist policies.
Upvote Downvote

 
White House Officials See More Labor Market Slack Than Fed Does - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Finance Chiefs Told Trade Tensions Are Hitting Confidence - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Coverfox gets $22 million funding from Transamerica, others

2018-04-18 livemint
Bengaluru: Glitterbug Technologies Pvt. Ltd, which owns online insurance platform Coverfox, has raised $22 million in a Series C funding round led by International Finance Corp. (IFC), the investment arm of the World Bank Group, and existing investor Transamerica.
Upvote Downvote

 
Comparison-shopping site sees steady interest in car loans after TRAIN

2018-04-18 bworldonline
MONEYGURU Philippines Corp., which operates financial comparison website MoneyMax.ph, said interest in car loans remained steady after the implementation of the tax reform law, driven by aggressive discounting and lower-end vehicles which are now taxed more lightly.
Upvote Downvote

 
Aegean Marine Petroleum Network Inc. Appoints Pavlos Papageorgiou as Chief Financial Officer

2018-04-17 globenewswire
NEW YORK, April 17, 2018 (GLOBE NEWSWIRE) -- Aegean Marine Petroleum Network Inc. (NYSE:ANW) (“Aegean” or “the Company”), a leading international marine fuel logistics company, today announced that Pavlos Papageorgiou has been appointed Chief Financial Officer, effective immediately. Mr. Papageorgiou succeeds Spyros Gianniotis, who will continue to act as an independent consultant to the Company to help ensure a seamless transition of financial and operational responsibilities.
Upvote Downvote

 
Clarida picked as Fed vice-chair; Powell’s inner circle takes shape

2018-04-17 bworldonline
US PRESIDENT Donald Trump announced his intention to nominate Richard Clarida, a respected monetary economist and Pacific Investment Management Co. global strategic adviser, as vice-chairman of the Federal Reserve.
Upvote Downvote

 
Activist investor Jana hired staff for new socially responsible fund

2018-04-17 reuters
NEW YORK (Reuters) - Jana Partners LLC, the activist investment firm now taking steps into socially responsible investing, has hired a portfolio manager and analyst to help oversee its effort of pushing companies to become better corporate citizens.
Upvote Downvote

 
Beijing Unsure How To Lobby DC; "Wei" In Weibo Rhymes With Gay; China Pushing EU Splittism?; National Security Day, There is A Party In Your Boardroom

2018-04-16 nb.sinocism
Happy Monday. This story from Tom Mitchell of the Financial Times stood out--China’s Xi Jinping says he is opposed to life-long rule - FT $$:
Upvote Downvote

 
Trump Is Planning to Name Pimco's Clarida as Fed Vice Chair - Bloomberg

2018-04-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

1
Global Growth Expected to Remain Robust Through 2019, IIF Says - Bloomberg

2018-04-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

1
RPT-Deloitte undertakes review of Abraaj's business, troubled fund-sources

2018-04-16 reuters
DUBAI, April 15 (Reuters) - Abraaj has hired Deloitte to examine its business, including its troubled $1 billion healthcare fund, after investors questioned an earlier review by KPMG of the embattled fund, people familiar with the matter said.
Upvote Downvote

 
China Warned Of Risk From Loaning To Fund OBOR!

2018-04-15 seekingalpha
The future of China is intricately interwoven with its far-reaching and encompassing One Belt One Road (OBOR) initiative. The program of monumental scope was launched in a fanfare of state-media publicity by Xi in 2013, this colossal program has become an extension of Beijing's global ambitions and the centerpiece of its economic foreign policy. Recently, while in China, International Monetary Fund Managing Director Christine Lagarde warned of the potential risks involved in Xi's grand global vision.
Upvote Downvote

 
Deloitte undertakes review of Abraaj's business, troubled fund-sources

2018-04-15 reuters
DUBAI (Reuters) - Abraaj has hired Deloitte to examine its business, including its troubled $1 billion healthcare fund, after investors questioned an earlier review by KPMG of the embattled fund, people familiar with the matter said.
Upvote Downvote

 
Weekly Commentary: Bizarre And Ominous

2018-04-15 seekingalpha
Things have gone from surreal to the bizarre. The President points blame directly at Putin for a chemical attack in Syria. Russia threatens to shoot down any missiles fired into Syria. President Trump tweets "Get ready Russia, because [missiles] will be coming, nice and new and 'smart!'" A presidential tweet the next morning provided an unequivocal update: "Could Take Place Very Soon Or Not So Soon At All.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...